Chlorogenic acid decreases glutamate release from rat cortical nerve terminals by p/q-type ca²⁺ channel suppression: A possible neuroprotective mechanism

The glutamatergic neurotransmitter system has received substantial attention in research on the pathophysiology and treatment of neurological disorders. The study investigated the effect of the polyphenolic compound chlorogenic acid (CGA) on glutamate release in rat cerebrocortical nerve terminals (synaptosomes). CGA inhibited 4-aminopyridine (4-AP)-induced glutamate release from synaptosomes. This inhibition was prevented in the absence of extracellular Ca²⁺ and was associated with the inhibition of 4-AP-induced elevation of Ca²⁺ but was not attributed to changes in synaptosomal membrane potential. In line with evidence observed through molecular docking, CGA did not inhibit glutamate release in the presence of P/Q-type Ca²⁺ channel inhibitors; therefore, CGA-induced inhibition of glutamate release may be mediated by P/Q-type Ca²⁺ channels. CGA-induced inhibition of glutamate release was also diminished by the calmodulin and Ca²⁺/calmo-dilin-dependent kinase II (CaMKII) inhibitors, and CGA reduced the phosphorylation of CaMKII and its substrate, synapsin I. Furthermore, pretreatment with intraperitoneal CGA injection attenu-ated the glutamate increment and neuronal damage in the rat cortex that were induced by kainic acid administration. These results indicate that CGA inhibits glutamate release from cortical synap-tosomes by suppressing P/Q-type Ca²⁺ channels and CaMKII/synapsin I pathways, thereby prevent-ing excitotoxic damage to cortical neurons.